mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.047 |
0.1 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |